Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Alongi

Showing results (251-260 of 305) with videos related to

Pageof 31
Sort By:
British Journal of Cancer|April 28, 2017
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric studyLuca Triggiani, Filippo Alongi, Michela Buglione, et al.
Advances in Radiation Oncology|February 24, 2022
Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-LinacStefania Naccarato, Michele Rigo, Roberto Pellegrini, et al.
Clinical and Translational Radiation Oncology|July 22, 2024
Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical diseaseLuca Nicosia, Andrea Gaetano Allegra, Niccolò Giaj-Levra, et al.
Critical Reviews in Oncology/Hematology|December 10, 2013
Salvage therapy of small volume prostate cancer nodal failures: a review of the literatureBerardino De Bari, Filippo Alongi, Michela Buglione, et al.
Cancers|May 14, 2022
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic TreatmentAndrea Emanuele Guerini, Alessandra Tucci, Filippo Alongi, et al.
Medical Oncology (Northwood, London, England)|May 19, 2021
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistanceLuca Triggiani, Rosario Mazzola, Davide Tomasini, et al.
International Journal of Radiation Oncology, Biology, Physics|June 5, 2024
Patient-Reported Outcomes Following Magnetic Resonance-Guided Radiation Therapy for Prostate Cancer: A Systematic Review and Meta-AnalysisJasmijn M Westerhoff, Tariq A Lalmahomed, Lieke T C Meijers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 5, 2018
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study)Icro Meattini, Nadia Pasinetti, Bruno Meduri, et al.
Clinical & Experimental Metastasis|November 8, 2021
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study groupCiro Franzese, Giulia Marvaso, Giulio Francolini, et al.
Cancers|May 11, 2024
Feasibility and Acute Toxicity of Hypo-Fractionated Radiotherapy on 0.35T MR-LINAC: The First Prospective Study in SpainDaniela Gonsalves, Abrahams Ocanto, Eduardo Meilan, et al.
Pageof 31

Showing results (251-260 of 305) with videos related to

Sort By:
Pageof 31
British Journal of Cancer|April 28, 2017
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric studyLuca Triggiani, Filippo Alongi, Michela Buglione, et al.
Advances in Radiation Oncology|February 24, 2022
Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-LinacStefania Naccarato, Michele Rigo, Roberto Pellegrini, et al.
Clinical and Translational Radiation Oncology|July 22, 2024
Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical diseaseLuca Nicosia, Andrea Gaetano Allegra, Niccolò Giaj-Levra, et al.
Critical Reviews in Oncology/Hematology|December 10, 2013
Salvage therapy of small volume prostate cancer nodal failures: a review of the literatureBerardino De Bari, Filippo Alongi, Michela Buglione, et al.
Cancers|May 14, 2022
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic TreatmentAndrea Emanuele Guerini, Alessandra Tucci, Filippo Alongi, et al.
Medical Oncology (Northwood, London, England)|May 19, 2021
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistanceLuca Triggiani, Rosario Mazzola, Davide Tomasini, et al.
International Journal of Radiation Oncology, Biology, Physics|June 5, 2024
Patient-Reported Outcomes Following Magnetic Resonance-Guided Radiation Therapy for Prostate Cancer: A Systematic Review and Meta-AnalysisJasmijn M Westerhoff, Tariq A Lalmahomed, Lieke T C Meijers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 5, 2018
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study)Icro Meattini, Nadia Pasinetti, Bruno Meduri, et al.
Clinical & Experimental Metastasis|November 8, 2021
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study groupCiro Franzese, Giulia Marvaso, Giulio Francolini, et al.
Cancers|May 11, 2024
Feasibility and Acute Toxicity of Hypo-Fractionated Radiotherapy on 0.35T MR-LINAC: The First Prospective Study in SpainDaniela Gonsalves, Abrahams Ocanto, Eduardo Meilan, et al.
Pageof 31